Gaming

Theorycraft Games Unveils First Title: Supervive, Coming to Open Beta Late 2024

Theorycraft Games has revealed SUPERVIVE (previously codenamed ‘Project Loki’) as the title of their first game, which will enter open beta in late 2024. SUPERVIVE is a neon-apocalyptic hero BR, set in an improvisational action sandbox where strategic, explosive shootouts meet a new era of storm chasing hunters – all with the aim of becoming the world’s next “10,000-hour game” for competitive squads. In celebration, Theorycraft is hosting their largest public playtest from June 27 to July 4. Players can pre-register here.

SUPERVIVE, a free-to-play, squad-based hero battle royale, has players team up in groups of two or four to battle enemies across a vast, sky-bound map while a deadly storm encroaches upon them. Players engage in dynamic combat, complete objectives, and use unique powers and equipment to devise creative strategies to outplay other teams and be the last squad standing. SUPERVIVE will always be free-to-play and is designed to ensure that cosmetics are the only in-game purchases, with no pay-for-power elements, ever.

“We left the security of our AAA jobs and founded Theorycraft to make a big bet on ourselves, to see if we could make the deepest games in the world, and to develop in a new way—out in the open with real players from day one,” said Theorycraft CEO, Joe Tung. “It’s been a wild ride to get to this point and we are proud to present SUPERVIVE as our first shot across the bow. We’re beyond grateful for our existing community and are super excited to welcome in new players!”

Key Features Include:

  • An Improvisational Action Sandbox: SUPERVIVE embraces open-ended abilities, powers, items, and world interactions, as well as physics-based combat and movement, allowing for expressive and intuitive action and traversal.
  • Combat and movement is easy to pick up, but also allows for endless depth and challenge in optimization
  • Play With Friends: Players can choose a number of ways to play, including a 4-player squad, 10 teams per lobby battle royale; a 2-per-squad duos battle royale with 20 teams; and 4v4 deathmatches.
  • Build Your Team of Storm Chasing Hunters: There are currently 15 hunters available, with more in-development for launch. While hunters do fall into one of three major archetypes (fighters, controllers, and supports), all are designed to be self-sufficient playmakers. All hunters have unique abilities (4 abilities, 1 ultimate, and a passive) and are all unlocked through regular play.
  • You’re Never Out Until You’re Out: There are many ways to bring your team back, including team-wide resurrection beacons, picking up downed allies in the middle of a fight, and even the ability to revive dead allies after the action has settled. That combined with SUPERVIVE’s high lethality and playmaking depth, it’s always possible to make that winning play.
  • Map-based Objectives and Storm Shifts: Each game can feature a random ‘storm shift’ that alters game variables—such as bullet trains, which place three high-speed, lethal trains on the map; nomadic storms, which move the available playspace across large distances; and more! Unique biome-specific monsters, bosses, and other game-changing mechanics come together for a world of systematic anarchy.
  • Beyond Launch: Theorycraft will forever be developing the game alongside the community – and the work won’t stop at launch. Expect new hunters, new storm shifts, new biomes, new powers, and lots, lots more—all for free!

More details about the public playtest can be found on the site here. Playtest slots are limited due to server constraints, so Theorycraft is employing a unique Twitch Drops campaign where players who watch more streams of SUPERVIVE have a higher chance of being selected to playtest.

Source: Theorycraft Games

Related Articles

The Settlers Reboot Launching on PC February 17th 2023

Richard Aizlewood

Call of Duty: Black Ops Cold War – Launches November 13th

nucleus

Overwatch 2 PvP Beta will go Live in Late April

nucleus

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More